Most read acne articles of 2022
This year, presentations and perspectives from dermatology’s biggest annual conferences comprise the majority of Healio’s most read acne articles of 2022.
Healio compiled the most read articles for this year related to the acne subspecialty, which included a story about vitamin A’s comparable, yet cautious, treatment in acne management compared with isotretinoin. Closely following was a story raising awareness of the need for comprehensive care in the transgender community.
Here are Healio’s top 10 acne stories of 2022:
Vitamin A may be a viable substitute for isotretinoin in acne
This past summer, a literature review analysis found vitamin A was comparable to isotretinoin in acne management. However, due to its potential for toxicity and over-the-counter accessibility, vitamin A should only be prescribed for acne management “with very careful attention to patient selection and education” and when isotretinoin is unavailable, according to the researchers. Read more.
Transgender patients with acne need culturally competent, comprehensive care
At the start of the year, dermatologists were raising awareness of clinical and mental health parameters when treating transgender patients for acne. It was suggested that attention should be given to transmasculine individuals receiving testosterone therapy, as acne is a common adverse event. Similarly, acne treatment for transfeminine patients requires specific and tailored care. Read more.
Clascoterone cream safely, effectively treats facial acne
At the 2022 American Academy of Dermatology (AAD) Annual Conference, researchers presented their findings concerning clascoterone cream and its effectiveness in treating facial acne vulgaris among patients aged 12 years and older. Read more.
VIDEO: Galderma launches Twyneo cream for acne
In an exclusive Healio video from the AAD Annual Conference, Hilary Baldwin, MD, medical director of the Acne Research Center in Brooklyn, New York, discussed the science behind Twyneo cream, the first combination of the two popular acne medications available as one formulation. Read more.
Triple combination IDP-126 reduces acne lesions
A fixed-dose triple combination topical gel formulation of clindamycin phosphate, benzoyl peroxide and adapalene reduced more than 70% of acne lesions in phase 2 and 3 trials, according to a poster presentation at the AAD Annual Conference. Researchers stated that, to their knowledge, these improvements were greater than any other improvements from an FDA approved topical drug in this indication. Read more.
VIDEO: Treat all acne as hormonal acne
Maui Derm for Dermatologists also makes an appearance on this list with an exclusive Healio video perspective from Julie C. Harper, MD, in which she gave an update on hormonal acne treatments for all populations. Read more.
VIDEO: 1,726 nm laser beneficial in acne treatment
Another Healio video perspective at Maui Derm for Dermatologists by Fernanda H. Sakamoto, MD, PhD, assistant professor of dermatology at Harvard Medical School, appears on the list of most read acne articles this year. In this video, Sakamoto discusses the use of lasers to treat acne. Read more.
1,726 nm laser effective in treating acne vulgaris
Closely following its video perspective is coverage of the actual study of the 1,726 nm laser, which expounds on the safety and efficacy of the technology in treating moderate to severe acne vulgaris. Read more.
Acne, scarring cause lasting psychological impacts
Individuals with acne and acne scarring experience deep psychological and physical burdens due to their conditions, according to a study Healio covered in July. In this study, participants wrote letters addressed to their disease which revealed consistent psychological themes. Read more.
Trifarotene plus doxycycline efficacious in severe acne treatment
Another presentation from the AAD meeting concludes this list. The presentation showed that rapid improvement in severe acne was observed in patients treated with 12 weeks of trifarotene and doxycycline. Read more.